Middle East & Africa AI in Bioinformatics Market is projected to register a substantial CAGR of 31.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation: Middle East and Africa AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Country (the Middle East and Africa). This region is further segmented into major countries such as Saudi Arabia, UAE, Israel, Egypt, South Africa, and Rest of the Middle East and Africa. Industry Trends and Forecast to 2029. Driver/Opportunity • Due to the rise in healthcare expenditure and strategic initiatives taken by key market players Market Players: Some of the key market players for the Middle East and Africa AI in bioinformatics market are listed below: • JADBio & Gnosis Data Analysis • SOPHiA GENETICS • Biomax Informatics AG • DNASTAR • Ardigen • QIAGEN • Source BioScience • NeoGenomics Laboratories • Eurofins Scientific • Illumina, Inc. • Thermo Fisher Scientific Inc. • CelbridgeScience • Dassault Systemes • Fios Genomics • Insilico Medicine • Strand Life Sciences • Paige AI, Inc. • SomaLogic Operating Co., Inc. • iNDX. Ai. • Elucidata

1 INTRODUCTION 27 1.1 OBJECTIVES OF THE STUDY 27 1.2 MARKET DEFINITION 27 1.3 OVERVIEW OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET 27 1.4 LIMITATIONS 29 1.5 MARKETS COVERED 30 2 MARKET SEGMENTATION 32 2.1 MARKETS COVERED 32 2.2 GEOGRAPHICAL SCOPE 33 2.3 YEARS CONSIDERED FOR THE STUDY 34 2.4 CURRENCY AND PRICING 34 2.5 DBMR TRIPOD DATA VALIDATION MODEL 35 2.6 MULTIVARIATE MODELLING 38 2.7 OFFERING LIFELINE CURVE 38 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39 2.9 DBMR MARKET POSITION GRID 40 2.10 MARKET SECTOR COVERAGE GRID 41 2.11 VENDOR SHARE ANALYSIS 42 2.12 SECONDARY SOURCES 43 2.13 ASSUMPTIONS 43 3 EXECUTIVE SUMMARY 44 4 PREMIUM INSIGHTS 47 4.1 PESTEL ANALYSIS 48 4.2 PORTER’S FIVE FORCES 49 5 MARKET OVERVIEW 50 5.1 DRIVERS 52 5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 52 5.1.2 GROWING DEMAND FOR BIOINFORMATICS 53 5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 53 5.2 RESTRAINTS 54 5.2.1 HIGH COST OF INSTRUMENTATION 54 5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 54 5.3 OPPORTUNITIES 55 5.3.1 RISE IN HEALTHCARE EXPENDITURE 55 5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 55 5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 56 5.4 CHALLENGES 56 5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 56 5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 57 6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING 58 6.1 OVERVIEW 59 6.2 SERVICES 62 6.3 SOFTWARE 62 6.4 OTHERS 63 7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE 65 7.1 OVERVIEW 66 7.2 MACHINE LEARNING 69 7.3 DEEP LEARNING 69 7.4 OTHERS 70 8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 72 8.1 OVERVIEW 73 8.2 BIOINFORMATICS SERVICES 76 8.2.1 DATA ANALYSIS 77 8.2.2 SEQUENCING SERVICES 77 8.2.3 DATABASE MANAGEMENT 77 8.2.4 OTHERS 77 8.3 BIOINFORMATICS PLATFORMS 77 8.3.1 SEQUENCE ANALYSIS PLATFORMS 78 8.3.2 SEQUENCE ALIGNMENT PLATFORMS 78 8.3.3 STRUCTURAL ANALYSIS PLATFORMS 79 8.3.4 SEQUENCE MANIPULATION PLATFORMS 79 8.3.5 OTHERS 79 8.4 KNOWLEDGE MANAGEMENT TOOLS 79 8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80 8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 80 9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 81 9.1 OVERVIEW 82 9.2 GENOMICS 85 9.3 CHEMOINFORMATICS & DRUG DESIGN 85 9.4 PROTEOMICS 86 9.5 DNA SEQUENCING 87 9.6 SYSTEM BIOLOGY 88 9.7 TRANSCRIPTOMICS 89 9.8 TEXT MINING 90 9.9 MICROARRAYS 91 9.10 METABOLOMICS 92 9.11 OTHERS 93 10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR 94 10.1 OVERVIEW 95 10.2 MEDICAL BIOTECHNOLOGY 98 10.3 ANIMAL BIOTECHNOLOGY 98 10.4 PLANT BIOTECHNOLOGY 99 10.5 ENVIRONMENTAL BIOTECHNOLOGY 100 10.6 FORENSIC BIOTECHNOLOGY 101 10.7 OTHERS 102 11 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY REGION 103 11.1 MIDDLE EAST AND AFRICA 104 11.1.1 SOUTH AFRICA 111 11.1.2 ISRAEL 114 11.1.3 SAUDI ARABIA 117 11.1.4 U.A.E 120 11.1.5 EGYPT 123 11.1.6 REST OF MIDDLE EAST AND AFRICA 126 12 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 127 12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 127 13 SWOT ANALYSIS 128 14 COMPANY PROFILES 129 14.1 ILLUMINA, INC. 129 14.1.1 COMPANY SNAPSHOT 129 14.1.2 REVENUE ANALYSIS 129 14.1.3 COMPANY SHARE ANALYSIS 130 14.1.4 PRODUCT PORTFOLIO 130 14.1.5 RECENT DEVELOPMENTS 130 14.2 DASSAULT SYSTEMES 131 14.2.1 COMPANY SNAPSHOT 131 14.2.2 REVENUE ANALYSIS 131 14.2.3 COMPANY SHARE ANALYSIS 132 14.2.4 PRODUCT PORTFOLIO 132 14.2.5 RECENT DEVELOPMENT 132 14.3 EUROFINS SCIENTIFIC 133 14.3.1 COMPANY SNAPSHOT 133 14.3.2 REVENUE ANALYSIS 133 14.3.3 COMPANY SHARE ANALYSIS 134 14.3.4 PRODUCT PORTFOLIO 134 14.3.5 RECENT DEVELOPMENTS 134 14.4 THERMO FISHER SCIENTIFIC INC. 135 14.4.1 COMPANY SNAPSHOT 135 14.4.2 REVENUE ANALYSIS 135 14.4.3 COMPANY SHARE ANALYSIS 136 14.4.4 PRODUCT PORTFOLIO 136 14.4.5 RECENT DEVELOPMENTS 136 14.5 QIAGEN 137 14.5.1 COMPANY SNAPSHOT 137 14.5.2 COMPANY SHARE ANALYSIS 137 14.5.3 PRODUCT PORTFOLIO 137 14.5.4 RECENT DEVELOPMENTS 137 14.6 SOPHIA GENETICS 138 14.6.1 COMPANY SNAPSHOT 138 14.6.2 PRODUCT PORTFOLIO 138 14.6.3 RECENT DEVELOPMENT 138 14.7 ARDIGEN 139 14.7.1 COMPANY SNAPSHOT 139 14.7.2 PRODUCT PORTFOLIO 139 14.7.3 RECENT DEVELOPMENTS 139 14.8 BIOMAX INFORMATICS AG 140 14.8.1 COMPANY SNAPSHOT 140 14.8.2 PRODUCT PORTFOLIO 140 14.8.3 RECENT DEVELOPMENT 140 14.9 CELBRIDGESCIENCE. 141 14.9.1 COMPANY SNAPSHOT 141 14.9.2 PRODUCT PORTFOLIO 141 14.9.3 RECENT DEVELOPMENTS 141 14.10 DNASTAR 142 14.10.1 COMPANY SNAPSHOT 142 14.10.2 PRODUCT PORTFOLIO 142 14.10.3 RECENT DEVELOPMENTS 142 14.11 ELUCIDATA 143 14.11.1 COMPANY SNAPSHOT 143 14.11.2 PRODUCT PORTFOLIO 143 14.11.3 RECENT DEVELOPMENTS 143 14.12 FIOS GENOMICS 144 14.12.1 COMPANY SNAPSHOT 144 14.12.2 PRODUCT PORTFOLIO 144 14.12.3 RECENT DEVELOPMENTS 144 14.13 INDX. AI. 145 14.13.1 COMPANY SNAPSHOT 145 14.13.2 PRODUCT PORTFOLIO 145 14.13.3 RECENT DEVELOPMENTS 145 14.14 INSILICO MEDICINE 146 14.14.1 COMPANY SNAPSHOT 146 14.14.2 PRODUCT PORTFOLIO 146 14.14.3 RECENT DEVELOPMENTS 146 14.15 JADBIO & GNOSIS DATA ANALYSIS 148 14.15.1 COMPANY SNAPSHOT 148 14.15.2 PRODUCT PORTFOLIO 148 14.15.3 RECENT DEVELOPMENTS 148 14.16 NEOGENOMICS LABORATORIES 150 14.16.1 COMPANY SNAPSHOT 150 14.16.2 REVENUE ANALYSIS 150 14.16.3 PRODUCT PORTFOLIO 151 14.16.4 RECENT DEVELOPMENTS 151 14.17 PAIGE AI, INC. 152 14.17.1 COMPANY SNAPSHOT 152 14.17.2 PRODUCT PORTFOLIO 152 14.17.3 RECENT DEVELOPMENTS 152 14.18 SOMALOGIC OPERATING CO., INC. 153 14.18.1 COMPANY SNAPSHOT 153 14.18.2 PRODUCT PORTFOLIO 153 14.18.3 RECENT DEVELOPMENTS 153 14.19 SOURCE BIOSCIENCE. 154 14.19.1 COMPANY SNAPSHOT 154 14.19.2 PRODUCT PORTFOLIO 154 14.19.3 RECENT DEVELOPMENTS 154 14.20 STRAND LIFE SCIENCES 155 14.20.1 COMPANY SNAPSHOT 155 14.20.2 PRODUCT PORTFOLIO 155 14.20.3 RECENT DEVELOPMENTS 155 15 QUESTIONNAIRE 156 16 RELATED REPORTS 159